Skip to main content

Research and statistics

332 results that are All research and statistics, sorted by Updated (newest)
From UK Health Security Agency (UKHSA)
  • Annual data from 2008 to 2019 for England.

  • Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.

  • This report (XXVI) is a review of suspected overexposures investigated by chromosomal aberration analysis.

  • Vaccine uptake data and commentary about the pertussis (whooping cough) vaccination programme for pregnant women.

  • Annual data of reported Campylobacter infections in England since 2006.

  • Notifications of scarlet fever disease in England and data from invasive group A streptococci (iGAS) surveillance.

  • Report presenting data for sexually transmitted infections (STIs) in the East of England.

  • Cumulative data showing the number of GP-registered patients in England having the seasonal influenza vaccine.

  • Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes not in Prevenar 13 vaccine.

  • Cumulative data on invasive pneumococcal disease (IPD) infections due to serotypes in Prevenar 13 in England.

  • Qualitative assessment of the risk that Crimean-Congo haemorrhagic fever presents to the UK population.

  • UK quarterly data and commentary on coverage achieved by the UK childhood immunisation programme.

  • England annual data on coverage achieved by the childhood immunisation programme.

  • Data showing the number and proportion of frontline healthcare workers (HCWs) in England having seasonal influenza and COVID-19 vaccines.

  • These reports summarise the performance of different lateral flow devices (LFDs) used across various test settings and services within the National Testing Programme.

  • This report outlines the findings of 2 large-scale asymptomatic testing interventions in education settings.

  • This report presents the comparison of the sensitivity data provided by the manufacturer in the instructions for use with that observed in the laboratories at Porton Down.

  • This paper presents empirical estimates of the impact of the TTSP scheme on testing uptake amongst those who received the payments.

  • Published papers by Public Health and Clinical Oversight team including modelling papers that outline the key points of testing for SARS-CoV-2.

  • Two evaluations commissioned to determine LFD performance when Delta and Omicron variants of SARS-CoV-2 were declared variants of concern (VOC) in the UK.